Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

zenith trials

posted on Dec 09, 2022 05:13PM

Could see Zenith Epigenetics get a similar SP lift with similar news in their Breast cancer trial or an FDA fast track on any of their clinical trials currently being done . Would love to see it happen

https://finance.yahoo.com/news/ambrx-shares-surge-encouraging-early-140448414.html

1 Recommendations

Re: zenith trials

Temsamany

Dec 09, 2022 11:28PM

Re: zenith trials

Toinv

Dec 10, 2022 12:31PM